HIV drug is Breakthrough of the Year

Science’s 2024 “Breakthrough of the Year” is Gilead’s drug Lenacapavir, an injectable drug that demonstrated remarkable success at preventing HIV infection with one shot every 6 months. The drug attaches to the lattice-like capsid proteins that shield the virus’s genetic material—a mechanism that could inspire other antivirals.

Ask us about availability of Lenacapavir for research.